Cutia Therapeutics
HKEX:2487
Balance Sheet
Balance Sheet Decomposition
Cutia Therapeutics
Cutia Therapeutics
Balance Sheet
Cutia Therapeutics
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
203
|
466
|
473
|
386
|
|
| Cash Equivalents |
203
|
466
|
473
|
386
|
|
| Short-Term Investments |
1 175
|
611
|
800
|
490
|
|
| Total Receivables |
1
|
4
|
77
|
105
|
|
| Accounts Receivables |
0
|
0
|
62
|
99
|
|
| Other Receivables |
1
|
4
|
15
|
6
|
|
| Inventory |
2
|
20
|
45
|
75
|
|
| Other Current Assets |
21
|
45
|
21
|
32
|
|
| Total Current Assets |
1 402
|
1 145
|
1 416
|
1 087
|
|
| PP&E Net |
51
|
229
|
231
|
228
|
|
| PP&E Gross |
51
|
229
|
231
|
228
|
|
| Accumulated Depreciation |
6
|
17
|
48
|
76
|
|
| Intangible Assets |
0
|
1
|
8
|
9
|
|
| Note Receivable |
14
|
37
|
42
|
59
|
|
| Other Long-Term Assets |
28
|
35
|
10
|
11
|
|
| Total Assets |
1 495
N/A
|
1 447
-3%
|
1 707
+18%
|
1 393
-18%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
134
|
110
|
|
| Accrued Liabilities |
13
|
38
|
49
|
46
|
|
| Short-Term Debt |
0
|
0
|
89
|
173
|
|
| Current Portion of Long-Term Debt |
4
|
9
|
51
|
52
|
|
| Other Current Liabilities |
2
|
31
|
45
|
39
|
|
| Total Current Liabilities |
19
|
77
|
255
|
323
|
|
| Long-Term Debt |
2 266
|
2 615
|
103
|
95
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2 285
N/A
|
2 693
+18%
|
358
-87%
|
419
+17%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1 050
|
1 506
|
3 337
|
3 702
|
|
| Additional Paid In Capital |
259
|
259
|
4 686
|
4 691
|
|
| Treasury Stock |
0
|
0
|
0
|
14
|
|
| Total Equity |
791
N/A
|
1 246
-58%
|
1 349
N/A
|
975
-28%
|
|
| Total Liabilities & Equity |
1 495
N/A
|
1 447
-3%
|
1 707
+18%
|
1 393
-18%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
304
|
304
|
304
|
320
|
|